Evaluation of Moisture Sorption Methods for Aqueous Moisture Barrier Coatings D. Tewari, R. Lewis, B. Kinsey and T. Dürig*

Similar documents
Table 1 Hydrophilicity of MC and HPMC Grades. Polymer Cloud Point ( C) Hydrophilicity MC HPMC Type 2910 HPMC Type

Hydrodynamic Robustness of Hypromellose and Methylcellulose Based Modified Release Matrix Systems D. Tewari, R. K. Lewis, W. W. Harcum and T Dürig

To study the effect that hydroxypropylcellulose (HPC) polymer molecular weight (MW) exerts on drug release rates and mechanism from matrix tablets.

PHARMACEUTICAL TECHNOLOGY REPORT. Introduction. Experimental Methods

PHARMACEUTICAL TECHNOLOGY REPORT. Abstract Summary. Introduction. Experimental Methods. Consumer Specialties ashland.com

Evaluation of different binders for roller compaction R. Wang, W. Liu, T. Durig

Comparative Evaluation of Enteric Film Coatings Applied in Organic Solvents

Direct Compression Formulation Using Starch 1500 with Ranitidine HCl (150 mg) Tablets, Film Coated with Opadry II (85F Series)

STARCH Application Data

Challenges and solutions for moisture sensitive API formulation

FROM SOLVENT TO AQUEOUS COATINGS. (Out of the Frying Pan...) Ralph E. Pondell. Coating Place, Inc. P.O. Box

Opadry Enteric. Application Data. Drug Release from Acrylic-Based Opadry Enteric (94 Series) Coated Tablets INTRODUCTION MATERIALS AND METHODS

Permeability Study on Cellulose Acetate Butyrate Coating Film

LubriTose Mannitol Michael Crowley, Director of R&D, Excipients

IJPRD, 2013; Vol 5(03): May-2013 ( ) International Standard Serial Number

Development of USP Delayed Release Aspirin Tablets using Opadry Enteric, Acrylic-Based Coating System

Table 1. Coating Parameters

Lactose Free, Direct Compression Formulation Used to Produce Loratadine (10 mg) Tablets

Eastman cellulose esters Pharmaceutical applications and drug delivery

Protection and Processing of a Highly Hygroscopic Herbal Extract by Drug Layering and Film Coating

The Effect of Film Coating and Storage Conditions on the Performance of Metformin HCl 500 mg Extended Release Hypromellose Matrices

DVA Symposium Mexico City Anisul Quadir Ph.D, MBA SE Tylose USA, Inc. (A Shin-Etsu Chemical Group Co.) Totowa, NJ

Direct Compression. With the right ingredients it s a simple, cost-effective manufacturing process

Easy, fast and reliable!

TABLET DESIGN AND FORMULATION

STARCH Proven and Trusted Excipient for Performance and Versatility EXCIPIENTS. Effective and economical disintegrant

Co-Processed Excipients: Regulatory Challenges. Carl Mroz Colorcon Limited June 2009

The Relevance of USP Methodology in the Development of a Verapamil Hydrochloride (240 mg) Extended Release Formulation

Biopharmaceutics Dosage form factors influencing bioavailability Lec:5

(51) Int Cl.: A61K 9/20 ( ) A61K 31/41 ( )

Critical material properties for the design of robust drug products : excipient functionality related characteristics

(12) Patent Application Publication (10) Pub. No.: US 2003/ A1

Comparison - Aqueous vs. Solvent based Ethylcellulose Films. H.S. Hall, K.D. Lillie & R.E. Pondell

Effect of Excipients on Dissolution: Case Studies with Bio-relevant/ Hydro-alcoholic Media

3. Drug or plant or excipients profile

EP B1 (19) (11) EP B1 (12) EUROPEAN PATENT SPECIFICATION

Functionalized Agricultural Packaging

Easy, fast and reliable!

REVISION OF MONOGRAPH ON TABLETS. Tablets

Effect of Common Excipients on the Oral Drug Absorption of Biopharmaceutics Classification System Class 3 Drugs

Kolliwax HCO. Technical Information. Hydrogenated castor oil powder for pharmaceutical use. = Registered trademark in many countries.

Kollicoat Smartseal 30 D Active Protection

SENTRY TM POLYOX Water Soluble Resins

KURARAY POVAL & EXCEVAL

Senior Scientist / Principal Scientist. Compounding Manager (Sterile and non-sterile specials) Senior Pharmaceutical Assessor

TECHNICAL INFORMATION RxCIPIENTS FM A versatile excipient for orally disintegrating tablet (ODT) formulations

Folic Acid in Human Nutrition

Excipient Quality & Trouble Shooting. By Seema Trivedi GM, Technical

we ve got you covered pharmaceutical product and solution guide

CONTENTS PAGE. Please note: Preface Matrix system Selection of METOLOSE grades Specifications

STUDY OF THE DETERIORATION OF ASPIRIN IN THE PRESENCE OF VARIOUS EXCIPIENTS

FORMULATION AND DEVELOPMENT OF ER METOPROLAOL SUCCINATE TABLETS

Evaluation of wetting and dispersing additives for the use in waterborne anticorrosive paints. Düsseldorf, , Martin Muth

EUDRAGIT L 100 and EUDRAGIT S 100

Assessment of Low Dose Content Uniformity of Indomethacin in Excipient Blends Using FT-Raman Mapping Spectroscopy

Office europeen des brevets. Publication number: Applicant: Chugai Seiyaku Kabushiki Kaisha 5-1, 5-chome, Ukima Kita-ku Tokyo(JP)

Etat des travaux du GDP

SUMMARY AND CONCLUSION

Dissolution control of direct compression tablets in different test media using novel pregelatinized starch, Swelstar TM MX-1

CHAPTER 5: FORMULATION OF SOLID DOSAGE FORM (TABLET & CAPSULES) INTRODUCTION

LYCOAT. New solutions for Film Coating from Roquette. LYCOAT for quicker quality coating

PHARMACEUTICAL AID PREPARED BY B.KIRUTHIGA LECTURER DEPT OF PHARMACEUTICAL CHEMISTRY

DESIGN AND EVALUATION OF CONTROLLED RELEASE MATRIX TABLETS OF FLURBIPROFEN

1. Gastric Emptying Time Anatomically, a swallowed drug rapidly reaches the stomach. Eventually, the stomach empties its content in the small

Wherever life takes you BASF excipients for orally disintegrating tablets make medication easy

Solving the solubility challenge: A key success factor of pharmaceutical formulations

Oy Publication number:

EUDRAGIT E 100, EUDRAGIT E PO and

Application of Starches, Modified Starches and Starch Derivatives in Pharmaceutical Products

Pharma & Food Solutions. POLYOX TM Water Soluble Resins Combining Flexibility with Consistency

Large scale production

ENHANCEMENT OF SOLUBILITY OF BICALUTAMIDE DRUG USING SOLID DISPERSION TECHNIQUE

Edible Films, Coatings & Processing Aids

EP A1 (19) (11) EP A1 (12) EUROPEAN PATENT APPLICATION. (43) Date of publication: Bulletin 2009/42

Excipient Functionality & Pharmacopoeia IPEC Europe Excipients Forum Nice, 5 February 2015

Formulation and Evaluation

4. Monitoring of dissolution induced changes in film coat

Typical Opadry II coating conditions with a product bed temperature of around o C were found to be suitable

Excipient Considerations for Continuous Manufacturing Implementation

Ingredients adapted to a fit for use model. APIs allowed the fit for use strategy to work. There has been a shift to designed for purpose

TABLET COATING 2. Lec. 9

Public Assessment Report. Scientific discussion. Sildenafil CF 20 mg, film-coated tablets. (sildenafil citrate) NL/H/3630/001/DC

EFFECT OF DENSITY AND POLYMER CONTENT ON THE HYGROSCOPIC THICKNESS SWELLING RATE OF COMPRESSION MOLDED WOOD FIBER/POLYMER COMPOSITES. Sheldon Q.

FLORITER. New Technology for Innovative Formulation Design.

Dextrol and Strodex Surfactant Selection Guide

EVALUATION OF EFFERVESCENT FLOATING TABLETS. 6.7 Mathematical model fitting of obtained drug release data

Research Paper The Effect of Different Superdisintegrants and their Concentrations on the Dissolution of Topiramate Immediate Release Tablets

Narrowing the gap between clinical capsule formulations and commercial film-coated tablets

Patient Information. VIREAD (VEER-ee-ad) (tenofovir disoproxil fumarate) tablets. (tenofovir disoproxil fumarate) oral powder

Revisions to USP 30 NF 25, Second Supplement

REGULATORY PERSPECTIVE. Dr. Raghunandan H V Associate Professor JSSCP, JSSU, Mysore

Technical brochure StarLac

Ion Exchange Resins. Unique Solutions to Formulation Problems

METOLOSE: CONTENTS PAGE

The binding performance of DFE Pharma Starch

SUSTAINED RELEASE TABLETS USING A PVA DC FORMULATION RESISTANT TO ALCOHOL INDUCED DOSE DUMPING

SAFETY DATA SHEET. Oxycodone Hydrochloride (CII) Capsule, 5mg, 100 count bottle NDC

KURARAY POVAL & EXCEVAL

International Journal of Research in Pharmaceutical and Nano Sciences Journal homepage:

Transcription:

PHARMACEUTICAL TECHNOLOGY REPORT Consumer Specialties ashland.com PTR-039-2 (Supersedes PTR-039-1) Page 1 of 9 Evaluation of Moisture Sorption Methods for Aqueous Moisture Barrier Coatings D. Tewari, R. Lewis, B. Kinsey and T. Dürig* Introduction Moisture is the most deleterious environmental factor with regard to chemical stability of actives (Monkhouse, 1984). Protection from environmental moisture is therefore an important concern in formulation development. Additionally, solid dosage forms containing elevated levels of residual water frequently exhibit physical changes such as altered dissolution, which can be associated with moistureinduced changes in crystal structure. The mechanism by which moisture exerts such physical and chemical changes generally entails adsorption of water vapor onto solid surfaces, with preferential location in amorphous domains, e.g. crystal lattice defects and amorphous polymers. The high concentration of water in these regions, acts as a potent plasticizer, enhancing molecular mobility. On the macroscopic level, gross changes in mechanical properties, e.g. hardening of tablets, partial swelling or disintegration, adhesion of dosage forms to each other and microbial spoilage are also possible. Well-known examples of moisture sensitive actives include aspirin, ranitidine, temazepam, most vitamins and numerous herbals. Formulators frequently guard against these unwanted effects by applying a moisture barrier coating to the affected dosage form. Traditionally such barrier coatings were based on combinations of hydrophobic or lipophilic additives and hydrophobic film forming polymers such as shellac, cellulose acetate phthalate (CAP) and ethyl cellulose. While effective, such systems require use of organic solvents with the attendant need for extensive environmental and safety precautions and costs. Additionally, the potential delay of drug dissolution caused by the hydrophobic barrier is frequently a concern. To overcome these shortcomings, water-dispersible moisture barrier coating systems have increasingly gained favor. For rational development of moisture barrier systems, a fundamental understanding of compositional factors that affect rate and extent of moisture sorption is important. This understanding allows for appropriate choices and levels of pigments, fillers, polymers, plasticizers and other additives. The objectives of this study were therefore to a) establish suitable methods to assess water vapor resistance of coatings, b) screen potential coating components for their barrier properties and c) develop an experimental, waterdispersible moisture barrier coating and compare to commercially available systems. Experimental methods Two methods were compared for their suitability to measure water repellency of barrier film coatings. These were direct gravimetric measurement of moisture sorption rates on coated and uncoated tablets exposed to various relative humidities, and measurement of water vapor transmission rate of free films. *This work was presented at the Annual Meeting of the American Association of Pharmaceutical Scientists, November 11-15, 2007, San Diego, California. All statements, information and data presented herein are believed to be accurate and reliable, but are not to be taken as a guarantee, an express warranty, or an implied warranty of merchantability or fitness for a particular purpose, or representation, express or implied, for which Ashland and its subsidiaries assume legal responsibility. Registered trademark, Ashland or its subsidiaries, registered in various countries. Trademark, Ashland or its subsidiaries, registered in various countries. *Trademark owned by a third party. 2011, Ashland. Rev. 03-2011

Page 2 of 9 Moisture sorption rates on coated tablets: Hygroscopic tablets (400 mg) comprising 5% croscarmellose as a hygroscopic wicking agent, 10% copper sulfate as a hygroscopic, hydrate-forming, model active and colorimetric moisture indicator and q.s. microcrystalline cellulose were compressed on Manesty Beta press. An additional model formulation comprising 325 mg aspirin was also evaluated. The tablets were coated in a O Hara Labcoat IIX coater equipped with a 15" perforated pan. Tablets were coated to 4 and 5% weight gain. Moisture uptake by uncoated and coated tablets was measured gravimetrically following the exposure to 75% relative humidity (RH) at 25 C. Compositional film coating variables included hygroscopicity of film forming cellulose polymer, inclusion of water-soluble plasticizers and inclusion of inorganic and lipophilic additives. Water vapor transmission rate (WVTR) of free films: Free films were cast onto glass plates. After equilibrating at 50% RH and room temperature, the water vapor transmission rate was measured using ASTM procedure E96 as follows: a film sample is sealed to the open mouth of a test dish containing desiccant. The assembly is then stored at 50% RH for 48 hours. The test unit is weighed periodically and the weight is plotted as a function of time. WVTR is calculated from the following equation: WVTR = G/t x = g.mm A. (m 2 )(24 Hour) Where, G is the weight gain in time, t, A is the area of exposed film and x is the film thickness. Comparisons with commercially available coating systems: Based on an understanding of fundamental compositional factors a novel water-dispersible moisture barrier system, Aquarius experimental moisture barrier coating system, was developed. Copper sulfate and aspirin tablets were coated with white pigmented versions of Aquarius experimental moisture barrier coating system, Opadry AMB complete film coating system, and Sepifilm LP 770 film coating system. Moisture barrier properties were assessed using the gravimetric moisture sorption method at 75% RH and 25 C. In addition general coating performance parameters such as coating times, % solids and appearance characteristics were evaluated. Materials 1. Aquarius experimental moisture barrier coating system, White, marketed by Aqualon a Business Unit of Ashland Inc., Wilmington, DE. 2. Opadry AMB complete film coating system, White, marketed by Colorcon, Inc. of Westpoint, PA. 3. Sepifilm LP 770 film coating system, White, marketed by Seppic, a subsidiary of Air Liquide, of Paris, France. 4. Klucel pharm hydroxypropylcellulose, marketed by Aqualon a Business Unit of Ashland Inc., Wilmington, DE. 5. Benecel pharm hypromellose, marketed by Aqualon a Business Unit of Ashland Inc., Wilmington, DE. 6. Aqualon sodium carboxymethylcellulose pharm, marketed by Aqualon a Business Unit of Ashland Inc., Wilmington, DE. 7. Cupric sulfate anhydrous, marketed by Spectrum Chemicals, Gardena, CA. 8. Ac-Di-Sol croscarmellose sodium, NF, marketed by FMC Corporation, Philadelphia, PA. 9. Microcrystalline cellulose: Avicel PH-102 Microcrystalline cellulose, NF, marketed by FMC Corporation, Philadelphia, PA. 10. Acetyl salicylic acid, USP, marketed by Ria International, East Hanover, NJ. 11. HyQual magnesium stearate, NF, marketed by Mallinckrodt Inc., a Division of Tyco International, St. Louis, MO. 12. Cab-O-Sil amorphous fumed silica (colloidal silicon dioxide), NF, marketed by Cabot Corporation, Tuscola, IL. 13. Hystrene 5016 NF Stearic acid, marketed by CK Witco, Memphis, TN. 14. Pregelatinized corn starch, Spress B820, marketed by Grain Processing Corporation, Muscatine, IA. 15. Lactose monohydrate, NF: Lactose Fast Flo, marketed by CHR Hansen, New Berlin, WI.

Page 3 of 9 Results and Discussion 1. Influence of Film Composition Effect of Hydrophilicity of the Film Forming Polymer: Film WVTR testing on neat polymer films indicates that moisture transmission is directly proportional to the hydrophilicity of the film forming polymer employed and follows the following rank order: Sodium carboxymethylcellulose (CMC)>> hypromellose (HPMC)>> Hydroxypropylcellulose (HPC) (Figure 1a). For reference, equilibrium moisture content at 75% RH, 25 C is approximately 25%, 15% and 11% for CMC, HPMC and HPC respectively. Similar behavior was reported by Okhamafe and York (2). A possible explanation is that the hydrophilic polymers interact strongly with water molecules, resulting in increased moisture sorption and plasticization, which in turn increases the diffusion constant for water vapor. Since WVTR is a product of the diffusion rate constant and the solubility coefficient, WVTR increases significantly. It is therefore apparent that the more hydrophilic the film is, the greater is the permeability to moisture. Copper sulfate tablets coated with pure polymer show the same trend with less moisture uptake into HPC coated tablets relative to HPMC coated tablets (Figure 1b). Effect of Inorganic Additives: Figure 2a shows that inclusion of an inorganic additive with plate-like morphology in HPC free films resulted in further reductions in film WVTR. It appears that the platy particles align perpendicular to the direction of the draw down. However, when applying analogous coating compositions onto copper sulfate model tablets, the moisture uptake increased for tablets that were coated with the combination of HPC and platy inorganic additive (Figure 2b). This divergence between results from free film WVTR studies and coated tablet moisture uptake could be due to different film formation processes. During casting of free films the inorganic platy additives align in the direction perpendicular to the drawdown, thereby increasing the tortuosity of the diffusion path. The film formation during pan coating occurs through sequential droplet deposition followed by rapid drying with increased likelihood of random alignment of any insoluble particulates. These randomly aligned inorganic additive particles would therefore tend to act as locators for film defects rather than as a diffusion barrier. Effect of Lipophilic Plasticizers: A divergence in results between free film and coated tablet moisture uptake data was also seen for lipophilic, water-insoluble plasticizers. Free film WVTR testing showed that the inclusion of lipophilic plasticizers to the polymer slightly reduces the water vapor transmission (Figure 3a). On the other hand, tablets coated with solution of polymer with lipophilic plasticizers had an opposite effect and showed no improvement in the barrier properties (Figure 3b). It is possible that phase separation occurred during the high shear atomizing spray application in the coating pan. Low MW lipophilic plasticizers have no effect on the barrier properties. Effect of Water Soluble Plasticizers: As shown in Figure 4a, presence of water-soluble plasticizer is detrimental in free films, whereas water soluble plasticizer had only marginal effect on the moisture uptake of coated copper sulfate tablets (4b). 2. Performance comparisons Comparison of moisture uptake rates: Aquarius experimental moisture barrier provided similar moisture barrier functionality on coated copper sulfate tablets when compared to Opadry AMB (Figure 5a). Sepifilm LP770 allowed significantly more moisture uptake. Figure 5b shows that on the aspirin formulation, the Aquarius experimental moisture barrier performed significantly better than Opadry AMB. General coating performance: Processing conditions for each coating system were optimized for the particular tablet formulation and coating pan configuration at hand. As shown in Table 1, Aquarius experimental moisture barrier can be sprayed at 20% solids versus the 12-15% of Sepifilm LP770, and can be coated much faster as a result. Although Opadry AMB can also be sprayed at high solids; the tackiness of the coating limits the application speed. Aquarius experimental moisture barrier can be applied at nearly twice the spray rate of Opadry AMB system.

Page 4 of 9 Conclusions Based on a study of compositional variables, a novel, water-dispersible moisture barrier coating system has been developed. This system has improved barrier function and processing efficiencies as compared to other commercially available coating systems. Additionally, this study highlights the importance of selecting appropriate test methods. WVTR measurement on free films provided largely contradictory data when compared to actual moisture uptake of coated tablets. Free film testing is widely used to assess gas permeability of coatings in a variety of applications; however results should be used cautiously in the context of spray-coated tablets. References: 1. Monkhouse, D. C, Drug Dev. Ind. Pharm., 10 (1984) 1373-1412. 2. Okhamafe, O.A et al, Pharm Acta Helv, 60 (3), 1985 Table 1: Coating Parameters for Aquarius experimental moisture barrier coating system and other commercially available barrier systems (All were white pigmented systems, coated in a O Hara Labcoat IIX Coater 15 Coating Pan) Aquarius Experimental Moisture Barrier Parameters Coating System Opadry AMB Sepifilm LP770 % Solids 19 20 14 Viscosity (cps) 341 230 448 Spray Rate (g/min) 20 10 20 Coating Time for 5 % 39 75 54 weight gain (min) Coating Time for 4% 32 60 43 weight gain (min) Bed Temperatures ( C) 40-45 55-59 40-45 Atomization Air 20 45 20 Pressure (PSI)

Page 5 of 9 Figure 1a Effect of polymer hydrophilicity on WVTR of neat polymer films. The rank order for hydrophilicity is CMC> HPMC >HPC. Figure 1b Effect of polymer hydrophilicity on moisture uptake of copper sulfate tablets coated with polymer only. HPMC is more hydrophilic than HPC.

Page 6 of 9 Figure 2a Effect of including an inorganic, platy additive on the WVTR of HPC films Figure 2b Effect of including and inorganic platy additive on moisture uptake of coated copper sulfate tablets

Page 7 of 9 Figure 3a Effect of lipophilic plasticizer on WVTR of HPC and HPMC films Figure 3b Effect of lipophilic plasticizer on moisture uptake of coated copper sulfate tablets

Page 8 of 9 Figure 4a Effect of water soluble plasticizer on WVTR of free films Figure 4b Effect of water soluble plasticizer on moisture uptake of coated copper sulfate tablets

Page 9 of 9 Figure 5a Comparison of Aquarius experimental moisture barrier coating system to commercial moisture barrier systems. Copper sulfate tablets were coated to 5% weight gain on a O Hara Labcoat IIX, 15" pan. Figure 5b Comparison of Aquarius experimental moisture barrier coating system and other marketed moisture barrier systems. Aspirin tablets were coated to 4% weight gain on a O Hara Labcoat IIX, 15" pan.